DE69740162D1 - Verwendung eines Pleuromutilinderivats in der Veterinärmedizin - Google Patents

Verwendung eines Pleuromutilinderivats in der Veterinärmedizin

Info

Publication number: DE69740162D1
Authority: DE; Germany
Prior art keywords: veterinary medicine; pleuromutilin derivative; veterinary; pleuromutilin; derivative
Prior art date: 1996-07-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69740162T

Other languages

English (en)

Inventor

David George Sidney Burch

Paul Howard Ripley

Erich Zeisl

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sandoz AG

Original Assignee

Sandoz AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-04

Filing date

1997-07-03

Publication date

2011-05-12

1996-07-04 Priority claimed from GBGB9614012.4A external-priority patent/GB9614012D0/en

1996-07-04 Priority claimed from GBGB9614019.9A external-priority patent/GB9614019D0/en

1996-07-04 Priority claimed from GBGB9614015.7A external-priority patent/GB9614015D0/en

1996-07-04 Priority claimed from GBGB9614016.5A external-priority patent/GB9614016D0/en

1996-07-04 Priority claimed from GBGB9614014.0A external-priority patent/GB9614014D0/en

1996-07-04 Priority claimed from GBGB9614013.2A external-priority patent/GB9614013D0/en

1996-07-04 Priority claimed from GBGB9614018.1A external-priority patent/GB9614018D0/en

1997-07-03 Application filed by Sandoz AG filed Critical Sandoz AG

2011-05-12 Application granted granted Critical

2011-05-12 Publication of DE69740162D1 publication Critical patent/DE69740162D1/de

2017-07-04 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Communicable Diseases (AREA)
Dermatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Emergency Medicine (AREA)
Oncology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Fodder In General (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Feed For Specific Animals (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DE69740162T 1996-07-04 1997-07-03 Verwendung eines Pleuromutilinderivats in der Veterinärmedizin Expired - Lifetime DE69740162D1 (de)

Applications Claiming Priority (8)

Application Number	Priority Date	Filing Date	Title
GBGB9614012.4A GB9614012D0 (en)	1996-07-04	1996-07-04	Organic compounds
GBGB9614019.9A GB9614019D0 (en)	1996-07-04	1996-07-04	Organic compounds
GBGB9614015.7A GB9614015D0 (en)	1996-07-04	1996-07-04	Organic compounds
GBGB9614016.5A GB9614016D0 (en)	1996-07-04	1996-07-04	Organic compounds
GBGB9614014.0A GB9614014D0 (en)	1996-07-04	1996-07-04	Organic compounds
GBGB9614013.2A GB9614013D0 (en)	1996-07-04	1996-07-04	Organic compounds
GBGB9614018.1A GB9614018D0 (en)	1996-07-04	1996-07-04	Organic compounds
GBGB9614017.3A GB9614017D0 (en)	1996-07-04	1996-07-04	Organic compounds

Publications (1)

Publication Number	Publication Date
DE69740162D1 true DE69740162D1 (de)	2011-05-12

Family

ID=27571326

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69740162T Expired - Lifetime DE69740162D1 (de)	1996-07-04	1997-07-03	Verwendung eines Pleuromutilinderivats in der Veterinärmedizin

Country Status (25)

Country	Link
US (1)	US6130250A (de)
EP (4)	EP1813272B1 (de)
JP (1)	JP4165769B2 (de)
CN (1)	CN1121216C (de)
AT (2)	ATE509625T1 (de)
AU (1)	AU718701B2 (de)
BG (1)	BG64369B1 (de)
BR (1)	BR9710208A (de)
CA (1)	CA2256514C (de)
CZ (4)	CZ298445B6 (de)
DE (1)	DE69740162D1 (de)
DK (2)	DK0910363T3 (de)
ES (2)	ES2364414T3 (de)
GB (1)	GB9614017D0 (de)
HU (1)	HU230325B1 (de)
IL (1)	IL127299A (de)
NO (1)	NO326117B1 (de)
NZ (1)	NZ333261A (de)
OA (1)	OA10951A (de)
PL (1)	PL189204B1 (de)
PT (2)	PT910363E (de)
RU (1)	RU2197237C2 (de)
SK (4)	SK286445B6 (de)
UA (1)	UA56173C2 (de)
WO (1)	WO1998001127A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9918037D0 (en) *	1999-07-30	1999-09-29	Biochemie Gmbh	Organic compounds
TWI260220B (en) *	1999-11-22	2006-08-21	Novartis Ag	A pharmaceutical composition for the transdermal treatment of bacterial infections in animals
TWI228048B (en) *	1999-12-09	2005-02-21	Novartis Ag	New formulation
GB0017031D0 (en) *	2000-07-11	2000-08-30	Biochemie Gmbh	Antimicrobials
US6682762B2 (en) *	2001-10-09	2004-01-27	Heart-O-Dixie Animal Nutrition, Llc	Poultry and livestock feed additive
CO5390081A1 (es)	2001-11-28	2004-04-30	Novartis Ag	Compuestos organicos
RU2287989C2 (ru) *	2004-02-25	2006-11-27	Общество с ограниченной ответственностью "ВИК-здоровье животных"	Препарат для профилактики и лечения заболеваний животных и птиц, вызванных микоплазмами или серпулинами в ассоциации с бактериями
EP1686115A1 (de) *	2005-01-26	2006-08-02	Novartis AG	Organische Säureadditionssalze von Valnemulin
DE102006021493B4 (de) *	2006-05-09	2010-04-01	Bruker Daltonik Gmbh	Massenspektrometrische Messung mikrobieller Resistenzen
EP2014645A1 (de) *	2007-07-13	2009-01-14	Nabriva Therapeutics AG	Pleuromutilin-derivate und ihre Verwendung als antimikrobielles Wirkungsmittel
CN101690717B (zh) *	2009-09-30	2013-03-06	北京大北农动物保健科技有限责任公司	一种兽用沃尼妙林及其盐的预混剂及制备方法
RU2418605C1 (ru) *	2009-10-16	2011-05-20	Государственное научное учреждение Научно-исследовательский ветеринарный институт Нечерноземной зоны РФ Российской академии сельскохозяйственных наук	Способ лечения респираторных болезней телят
RU2416431C1 (ru) *	2009-10-16	2011-04-20	Государственное научное учреждение Научно-исследовательский ветеринарный институт Нечерноземной зоны РФ Российской академии сельскохозяйственных наук	Способ лечения респираторных болезней телят
CN102415989A (zh) *	2011-09-30	2012-04-18	上海恒丰强动物药业有限公司	盐酸沃尼妙林溶液剂及其制备方法
CN103520099A (zh) *	2013-10-30	2014-01-22	王玉万	含有效成份为沃尼妙林的长效注射剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4130709A (en) *	1977-12-08	1978-12-19	Eli Lilly And Company	Pleuromutilin glycoside derivatives
US4247542A (en) *	1978-06-22	1981-01-27	Eli Lilly And Company	A-40104 Antibiotics and process for production thereof
DE3413708A1 (de) *	1984-04-12	1985-10-24	Sandoz-Patent-GmbH, 7850 Lörrach	Neue pleuromutilinderivate, verfahren zu ihrer herstellung und ihre verwendung
EP0153277B1 (de) *	1984-02-17	1987-08-26	Sandoz Ag	Neue Pleuromutilinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE3405632A1 (de) *	1984-02-17	1985-08-22	Sandoz-Patent-GmbH, 7850 Lörrach	Neue pleuromutilinderivate, verfahren zu ihrer herstellung und ihre verwendung
HU208115B (en) *	1989-10-03	1993-08-30	Biochemie Gmbh	New process for producting pleuromutilin derivatives
AT392272B (de) *	1989-10-03	1991-02-25	Biochemie Gmbh	Verfahren zur herstellung eines pleuromutilinderivats und seiner saeureadditionssalze
AT400674B (de) *	1991-07-24	1996-02-26	Biochemie Gmbh	Pharmazeutische pleuromutilin-zubereitung
CN1039585C (zh) *	1993-01-01	1998-08-26	生化企业	截短侧耳素衍生物与环糊精的配合物和含有它的药物制剂

1996
- 1996-07-04 GB GBGB9614017.3A patent/GB9614017D0/en active Pending
1997
- 1997-03-07 UA UA99010014A patent/UA56173C2/uk unknown
- 1997-07-03 EP EP06127207A patent/EP1813272B1/de not_active Expired - Lifetime
- 1997-07-03 SK SK5099-2006A patent/SK286445B6/sk not_active IP Right Cessation
- 1997-07-03 DK DK97933652.6T patent/DK0910363T3/da active
- 1997-07-03 BR BR9710208A patent/BR9710208A/pt not_active Application Discontinuation
- 1997-07-03 AT AT97933652T patent/ATE509625T1/de not_active IP Right Cessation
- 1997-07-03 SK SK5100-2006A patent/SK286431B6/sk not_active IP Right Cessation
- 1997-07-03 CZ CZ20070003A patent/CZ298445B6/cs not_active IP Right Cessation
- 1997-07-03 EP EP06127211A patent/EP1810672A1/de not_active Withdrawn
- 1997-07-03 JP JP50476398A patent/JP4165769B2/ja not_active Expired - Lifetime
- 1997-07-03 PT PT97933652T patent/PT910363E/pt unknown
- 1997-07-03 CZ CZ20070002A patent/CZ298444B6/cs not_active IP Right Cessation
- 1997-07-03 PT PT06127207T patent/PT1813272E/pt unknown
- 1997-07-03 HU HU9903103A patent/HU230325B1/hu unknown
- 1997-07-03 DE DE69740162T patent/DE69740162D1/de not_active Expired - Lifetime
- 1997-07-03 SK SK5098-2006A patent/SK285857B6/sk not_active IP Right Cessation
- 1997-07-03 CN CN97196038A patent/CN1121216C/zh not_active Expired - Lifetime
- 1997-07-03 DK DK06127207.6T patent/DK1813272T3/da active
- 1997-07-03 CZ CZ20070004A patent/CZ298446B6/cs not_active IP Right Cessation
- 1997-07-03 AT AT06127207T patent/ATE503475T1/de not_active IP Right Cessation
- 1997-07-03 PL PL97330726A patent/PL189204B1/pl unknown
- 1997-07-03 EP EP97933652A patent/EP0910363B1/de not_active Expired - Lifetime
- 1997-07-03 WO PCT/EP1997/003518 patent/WO1998001127A1/en not_active Ceased
- 1997-07-03 ES ES97933652T patent/ES2364414T3/es not_active Expired - Lifetime
- 1997-07-03 EP EP06127213A patent/EP1808171A1/de not_active Withdrawn
- 1997-07-03 IL IL12729997A patent/IL127299A/xx not_active IP Right Cessation
- 1997-07-03 ES ES06127207T patent/ES2360813T3/es not_active Expired - Lifetime
- 1997-07-03 AU AU36929/97A patent/AU718701B2/en not_active Expired
- 1997-07-03 CA CA002256514A patent/CA2256514C/en not_active Expired - Lifetime
- 1997-07-03 RU RU99102247/13A patent/RU2197237C2/ru active
- 1997-07-03 SK SK27-99A patent/SK285711B6/sk not_active IP Right Cessation
- 1997-07-03 CZ CZ0438198A patent/CZ298385B6/cs not_active IP Right Cessation
- 1997-07-03 US US09/214,164 patent/US6130250A/en not_active Expired - Lifetime
- 1997-07-03 NZ NZ333261A patent/NZ333261A/xx not_active IP Right Cessation
1998
- 1998-12-08 BG BG103002A patent/BG64369B1/bg unknown
- 1998-12-30 NO NO986198A patent/NO326117B1/no not_active IP Right Cessation
1999
- 1999-01-04 OA OA9900001A patent/OA10951A/en unknown

Also Published As

Publication number	Publication date
PL330726A1 (en)	1999-05-24
SK2799A3 (en)	1999-09-10
ES2364414T3 (es)	2011-09-01
SK286445B6 (sk)	2008-10-07
ATE503475T1 (de)	2011-04-15
CN1223576A (zh)	1999-07-21
CZ298444B6 (cs)	2007-10-03
CZ298446B6 (cs)	2007-10-03
CZ298445B6 (cs)	2007-10-03
CA2256514A1 (en)	1998-01-15
PT1813272E (pt)	2011-04-29
UA56173C2 (uk)	2003-05-15
CA2256514C (en)	2006-11-28
JP4165769B2 (ja)	2008-10-15
HUP9903103A3 (en)	2000-04-28
RU2197237C2 (ru)	2003-01-27
NO986198D0 (no)	1998-12-30
EP0910363A1 (de)	1999-04-28
EP0910363B1 (de)	2011-05-18
AU718701B2 (en)	2000-04-20
EP1813272A1 (de)	2007-08-01
HUP9903103A2 (hu)	2000-02-28
DK1813272T3 (da)	2011-07-18
GB9614017D0 (en)	1996-09-04
BG64369B1 (bg)	2004-12-30
OA10951A (en)	2003-02-26
SK285857B6 (sk)	2007-09-06
CZ298385B6 (cs)	2007-09-19
JP2000514072A (ja)	2000-10-24
NO326117B1 (no)	2008-09-29
PT910363E (pt)	2011-05-31
AU3692997A (en)	1998-02-02
SK285711B6 (sk)	2007-06-07
BR9710208A (pt)	1999-08-10
DK0910363T3 (da)	2011-09-05
EP1813272B1 (de)	2011-03-30
SK286431B6 (sk)	2008-10-07
IL127299A (en)	2005-05-17
EP1810672A1 (de)	2007-07-25
US6130250A (en)	2000-10-10
ATE509625T1 (de)	2011-06-15
NO986198L (no)	1998-12-30
WO1998001127A1 (en)	1998-01-15
CZ438198A3 (cs)	1999-03-17
HU230325B1 (hu)	2016-02-29
PL189204B1 (pl)	2005-07-29
BG103002A (en)	1999-09-30
EP1808171A1 (de)	2007-07-18
IL127299A0 (en)	1999-09-22
CN1121216C (zh)	2003-09-17
NZ333261A (en)	2000-09-29
ES2360813T3 (es)	2011-06-09

Publication	Publication Date	Title
ATE509625T1 (de)	2011-06-15	Verwendung eines pleuromutilinderivats in der veterinärmedizin
ATE120644T1 (de)	1995-04-15	Verwendung von 1,3-oxathiolanalogen von nukleosiden zur herstellung eines arzneimittels zur behandlung von hepatitis-b.
DK1223980T3 (da)	2003-09-15	Anvendelse af CSF-1-inhibitorer
RU94036758A (ru)	1996-08-27	Применение 2-фенил-3-ароилбензотиофенов для лечения пери-менопаузного синдрома
DE69100364D1 (de)	1993-10-21	Verwendung von N-Myristoyl-(S)-Phenylalanin zur Herstellung eines Medikaments zur Behandlung von Krankheiten mittels Hemmung der Myristoylierung.
DE69327399D1 (de)	2000-01-27	Verwendung von stoffen für die herstellung eines medikaments für geflügel
RU94044454A (ru)	1996-10-10	Ингибитор аутоимунных заболеваний
RU93032613A (ru)	1996-06-20	Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
DE69116380D1 (de)	1996-02-22	Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
ATE450535T1 (de)	2009-12-15	Neues verfahren zur herstellung von pleuromutilinderivaten
RU94044321A (ru)	1996-10-20	Средство повышения либидо у женщин постклимактерического периода
ATE191849T1 (de)	2000-05-15	Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
RU94044356A (ru)	1996-10-10	Применение 2-фенил-3-ароилбензотиофенов для увеличения экспрессии тромбомодулина для ингибирования тромботического расстройства, для увеличения активации протеина с
ATE202704T1 (de)	2001-07-15	Verwendung eines natrium- oder lysiniumsalzes von crotonsäureamidderivaten zur herstellung eines arzneimittels zur behandlung von krebserkrankungen
ATE339202T1 (de)	2006-10-15	Verwendung von alpha-halogenacryloyl-distamycin derivaten zur herstellung eines medikaments zur behandlung von krebs
SE9101840L (sv)	1992-12-15	Ny medicinsk anvaendning
EP1062948A4 (de)	2002-07-17	Arzneimittel für diastolische herzerkrankungen
ATE239492T1 (de)	2003-05-15	Verwendung von einem bpi protein zur herstellung eines medikamentes zur behandlung von chronischen herzerkrankungen
MX9701332A (es)	1997-05-31	Metodos para curar y reparar fracturas oseas.
ATE186640T1 (de)	1999-12-15	Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung neurogenerativer erkrankungen
ATE278683T1 (de)	2004-10-15	Thienylcyclohexan-derivte zur herstellung von thienylcyclohexylen
DE69228235D1 (de)	1999-03-04	Verwendung eines Mittels zur Herstellung eines Arzneimittels zur Behandlung von Lebererkrankung
RU94010369A (ru)	1996-08-10	Способ получения производных инсулина
ATE108653T1 (de)	1994-08-15	Verwendung von dopamin-agonisten zur herstellung eines arzneimittels für die behandlung von knochenverletzungen.
SE8900685D0 (sv)	1989-02-28	New compounds